Research Seminar – Dr. Ryan D’Arcy: Neurotechnology advances in brain vital sign monitoring: From hospitals to diverse point-of-care settings

–

Location:
SHRM B1001, Gordon B. Shrum Building

–

Talk title: Neurotechnology advances in brain vital sign monitoring: From hospitals to diverse point-of-care settings

–

Abstract: Neurotechnology advances in hospital-based medical imaging labs continue to probe brain function at deeper levels. Our own work has done so in highly resolved white matter imaging studies. Translating these capabilities to diverse points of care remains a major focus for innovation in biomedical engineering; from basic research to commercialization. This talk will describe this journey through the development of the scientific brain vital signs framework and corresponding deployment of the medical device, the NeuroCatch Platform. Deployed globally, an overview of emerging NeuroCatch applications will cover the neurology, mental health, and performance aspects of brain vital sign monitoring beyond the lab.

–

–

Dr. Ryan D’Arcy is a neuroscientist and health technology executive with 30 years of experience in translating brain science into clinical solutions. As Co-founder of HealthTech Connex, he led the development of NeuroCatch®, an FDA-registered neurotechnology platform for assessing brain function. He is a full Professor and Endowed Chair at SFU and has affiliations with UBC, including the Djavad Mowafaghian Centre for Brain Health.

With over 300 peer-reviewed publications and multiple patents, Dr. D’Arcy has secured more than $100 million in research funding. He pioneered the concept of brain vital signs for quick, non-invasive cognitive evaluations in cases of concussion and neurodegenerative diseases, leading to the widespread adoption of NeuroCatch in clinical trials and hospitals.

An expert at the intersection of neuroscience and medical devices, Dr. D’Arcy has successfully built research-driven technology programs and mentored over 300 professionals, maintaining a strong emphasis on commercialization alongside scientific rigor to bring neurotechnology to market effectively.